Primmune Therapeutics, Inc.

Pharmaceutical company · San Diego, California, United States

Primmune Therapeutics, Inc. is a pharmaceutical company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $13 million sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

Primmune Therapeutics at a glance

Typepharmaceutical company
HeadquartersSan Diego, California, United States
Earliest incorporation on record2017
SEC CIK1721931

What does Primmune Therapeutics do?

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $13 million sold (2020).

Frequently asked questions about Primmune Therapeutics

Where is Primmune Therapeutics headquartered?

Primmune Therapeutics, Inc. is headquartered in San Diego, California, United States.

What does Primmune Therapeutics do?

Primmune Therapeutics, Inc. is a pharmaceutical company.

When was Primmune Therapeutics founded?

The earliest incorporation on record for Primmune Therapeutics, Inc. is in 2017, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences